We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
News Corp Class A
NWSA
$15.4B
| $7.73M | 0.05% |
482,995
-50,944
| -10% | -$825K |
|
327
Benchmark Electronics
BHE
$2.96B
| $7.71M | 0.05% |
320,978
-130,885
| -29% | -$3.12M |
|
328
Westlake Corp
WLK
$9.9B
| $7.63M | 0.05% |
106,096
-290,584
| -73% | -$18.6M |
|
329
Progress Software
PRGS
$1.76B
| $7.6M | 0.05% |
279,603
-32,594
| -10% | -$862K |
|
|
VRE
330
DELISTED
Veris Residential
VRE
| $7.54M | 0.05% |
391,232
+21,700
| +6% | +$419K |
|
331
Telkom Indonesia
TLK
$14.9B
| $7.51M | 0.05% |
345,210
-743,162
| -68% | -$16.7M |
|
332
Grupo Aeroportuario del Sureste
ASR
$8.3B
| $7.46M | 0.05% |
55,476
-869
| -2% | -$116K |
|
333
Meta Platforms (Facebook)
META
$1.51T
| $7.43M | 0.05% |
+90,432
| New | +$7.08M |
|
334
TriNet
TNET
$3.14B
| $7.43M | 0.05% |
210,854
+26,443
| +14% | +$911K |
|
|
UFS
335
DELISTED
DOMTAR CORPORATION (New)
UFS
| $7.4M | 0.05% |
160,108
-83,762
| -34% | -$3.53M |
|
|
DENN
336
DELISTED
Denny's
DENN
| $7.37M | 0.05% |
646,864
+259,958
| +67% | +$2.9M |
|
|
FFG
337
DELISTED
FBL Financial Group
FFG
| $7.33M | 0.05% |
118,150
-4,601
| -4% | -$261K |
|
338
MKS Inc
MKSI
$20.6B
| $7.33M | 0.05% |
216,663
+60,553
| +39% | +$2.13M |
|
339
Novartis
NVS
$297B
| $7.31M | 0.05% |
82,696
-1,561,981
| -95% | -$139M |
|
340
Encompass Health
EHC
$12.4B
| $7.28M | 0.04% |
206,377
-345,628
| -63% | -$11.8M |
|
341
Bio-Rad Laboratories Class A
BIO
$9.42B
| $7.26M | 0.04% |
53,720
-1,275
| -2% | -$158K |
|
|
DNB
342
DELISTED
Dun & Bradstreet
DNB
| $7.24M | 0.04% |
56,421
+35,906
| +175% | +$4.5M |
|
|
SPTN
343
DELISTED
SpartanNash
SPTN
| $7.22M | 0.04% |
228,812
+7,344
| +3% | +$198K |
|
344
Sabesp
SBS
$18.7B
| $7.18M | 0.04% |
6,835,569
-18,290,376
| -73% | -$19.6M |
|
|
XXIA
345
DELISTED
Ixia
XXIA
| $7.17M | 0.04% |
590,976
+67,614
| +13% | +$750K |
|
346
Viavi Solutions
VIAV
$9.66B
| $7.16M | 0.04% |
959,968
+27,544
| +3% | +$209K |
|
347
Cadence Design Systems
CDNS
$93.4B
| $7.16M | 0.04% |
+388,055
| New | +$7.07M |
|
|
LSI
348
DELISTED
Life Storage, Inc.
LSI
| $7.14M | 0.04% |
114,023
-25,341
| -18% | -$1.57M |
|
349
Reinsurance Group of America
RGA
$16.1B
| $7.02M | 0.04% |
75,298
+92
| +0.1% | +$8.13K |
|
350
Itron
ITRI
$4.54B
| $6.99M | 0.04% |
191,445
+137,800
| +257% | +$5.13M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.